Moving Stocks: ArQule Inc. (NASDAQ:ARQL), Exelixis, Inc. (NASDAQ:EXEL), ProAssurance Corporation (NYSE:PRA), Sonus Networks, Inc. (NASDAQ:SONS), Capital Product Partners L.P. (NASDAQ:CPLP)

On 29 February, ArQule Inc. (NASDAQ:ARQL) announced it has entered into definitive agreements with certain institutional and accredited investors to raise approximately $15.3 million in gross proceeds in a registered direct offering through the sale of 8,027,900 shares of common stock at an offering price of $1.90 per share.

ArQule Inc. (NASDAQ:ARQL) belongs to Healthcare sector. Its weekly performance is -8.72%. On last trading day company shares ended up at $1.78. ArQule Inc. (NASDAQ:ARQL) distance from 50-day simple moving average (SMA50) is -16.65%.

On 29 February, Exelixis, Inc. (NASDAQ:EXEL) and Ipsen (Euronext: IPN; ADR: IPSEY) jointly announced an exclusive licensing agreement for the commercialization and further development of cabozantinib, Exelixis’ lead oncology drug. Under the agreement, Ipsen will have exclusive commercialization rights for current and potential future cabozantinib indications outside of the United States, Canada and Japan.

Exelixis, Inc. (NASDAQ:EXEL) shares moved down -0.26% in last trading session and ended the day at $3.86. EXEL Gross Margin is 89.60% and its return on assets is -60.30%. Exelixis, Inc. (NASDAQ:EXEL) quarterly performance is -32.99%.

ProAssurance Corporation (NYSE:PRA) announced a quarterly dividend. Shareholders of record on Wednesday, March 30th will be paid a dividend of 0.31 per share on Tuesday, April 12th. This represents a $1.24 dividend on an annualized basis and a yield of 2.45%.

On 03 March, ProAssurance Corporation (NYSE:PRA) shares moved down -1.78% and was closed at $49.76. PRA EPS growth in last 5 year was -10.10%. ProAssurance Corporation (NYSE:PRA) year to date (YTD) performance is 2.53%.

Sonus Networks, Inc. (NASDAQ:SONS)‘s stock had its “buy” rating restated by Zacks Investment Research in a research report issued on Monday, reports. They presently have a $6.75 price objective on the stock. Zacks Investment Research‘s target price would indicate a potential upside of 26.76% from the stock’s current price.

Sonus Networks, Inc. (NASDAQ:SONS) ended the last trading day at $7.74. Company weekly volatility is calculated as 3.28% and price to cash ratio as 3.53. Sonus Networks, Inc. (NASDAQ:SONS) showed a weekly performance of 4.31%.

On 29 February, Capital Product Partners L.P. (NASDAQ:CPLP) announced the successful delivery of the M/V ‘CMA CGM Magdalena’. Pursuant to the Master Vessel Acquisition Agreement we entered into on July 24, 2014, the Partnership took delivery on February 26, 2016 of the M/V ‘CMA CGM Magdalena’ (115,639 dwt / 9,288 TEU, Eco-Flex, Wide Beam Containership built 2016, Daewoo-Mangalia Heavy Industries S.Α.), the last of five vessels (the ‘Dropdown Vessels’) that we have agreed to acquire from our sponsor, Capital Maritime & Trading Corp.

Capital Product Partners L.P. (NASDAQ:CPLP) shares moved up 3.71% in last trading session and ended the day at $3.63. CPLP Gross Margin is 96.90% and its return on assets is 2.80%. Capital Product Partners L.P. (NASDAQ:CPLP) quarterly performance is -39.21%.

Leave a Reply

Your email address will not be published. Required fields are marked *